Explore: Medtech · Seed · Switzerland · United States · Europe
Neurosoft Bioelectronics
seed · 🇨🇭 Geneva, Switzerland · Founded 2020
Swiss neurotechnology company developing minimally invasive brain-computer interface (BCI) platforms using soft and stretchable neural interfaces. Neurosoft Bioelectronics is a deeptech, healthtech and medtech startup based in Geneva, Switzerland, founded 2020, at seed stage, with $7.5M raised to date.
Neurosoft Bioelectronics is tracked live on Scout, Fusion42's database of newly funded startups — its profile updates as new rounds, backers and Wire analysis land.
Total raised
$7.5M
Stage
seed
Business model
hardware
Target customer
Hospitals, neurosurgeons, and clinical research centers treating neurological disorders such as epilepsy, tinnitus, and brain tumors
Sectors
Backed by
Frequently asked questions
- What does Neurosoft Bioelectronics do?
- Swiss neurotechnology company developing minimally invasive brain-computer interface (BCI) platforms using soft and stretchable neural interfaces.
- Where is Neurosoft Bioelectronics based?
- Neurosoft Bioelectronics is based in Geneva, Switzerland, founded in 2020.
- How much has Neurosoft Bioelectronics raised?
- Neurosoft Bioelectronics has raised $7.5M in tracked funding and is currently at the seed stage.
- Who has invested in Neurosoft Bioelectronics?
- Investors in Neurosoft Bioelectronics include Skybound Venture Capital.